Pressroom: Media Coverage

Showing 501 - 520 of 727 news items


Do You Speak Sunscreen?

Dermatologist Steven Wang explained what the new FDA regulations for sunscreen labels mean.

June 8, 2012
Best Doctors

Seventy-nine Memorial-Sloan Kettering doctors were listed in New York Magazine’s annual Best Doctors issue.

June 5, 2012
Best Children's Hospitals

Memorial Sloan Kettering ranked number 11 among the top 50 pediatric cancer hospitals in U.S. News & World Report’s annual Best Children’s Hospitals issue. The New York Daily News reported on the rankings.

June 5, 2012
The Trouble With ‘Doctor Knows Best’

Epidemiologist and physician Peter Bach authored an essay opining that many doctors will ignore current recommendations to screen for cancer less often and continue to practice as they have been.

June 5, 2012
Childhood Cancer Survivors Face Higher Breast Cancer Risk

Research led by biostatistician Chaya Moskowitz and released at the American Society of Clinical Oncology’s Annual Meeting found that women treated with radiation to the chest for childhood cancer have a high risk of developing breast cancer at a young age – a risk that is comparable to that of women who have mutations in BRCA1 or BRCA2 genes. Coverage appeared in The Wall Street Journal, USA Today, The Associated Press, HealthDay News, and

June 4, 2012
In Study, Drug Delays Worsening of Breast Cancer, with Fewer Side Effects

Breast Cancer Medicine Service Chief Clifford Hudis commented on data released at the American Society of Clinical Oncology’s Annual Meeting that showed that an experimental new drug called TDM-1 delayed the progression of breast cancer with significantly fewer side effects than traditional chemotherapy. Dr. Hudis was also quoted in, and medical oncologist Shanu Modi discussed the data in Bloomberg.

June 3, 2012
Bristol Immune Drug Shows Promise in Three Cancers

Data released at the American Society of Clinical Oncology’s Annual Meeting showed that an experimental new drug, known as an anti-PD-1 treatment, shrunk tumors in patients with several cancers by boosting the body’s own immune system. Immunologist James Allison, whose pioneering work contributed to the first FDA-approved immunotherapy drug ipilimumab (Yervoy™), was quoted. Thoracic Oncology Service Chief Mark Kris also commented on the data in and medical oncologist Jedd Wolchok was quoted in Nature.

June 2, 2012
PSA Test Part of Trend: Fewer Screenings for Well People

Epidemiologist and physician Peter Bach explored the growing concern about overtesting and overtreating patients due to increased recognition of risks and side effects.

May 28, 2012
Red Hook Movie Producer Wants to Raise Awareness of Stomach Cancer

Medical oncologist Yelena Janjigian was interviewed about her patient, Red Hook movie producer Angelica Strong, who is organizing fundraisers to raise awareness and funds for stomach cancer.

May 27, 2012
Considering the Personal and Practical Decisions with Breast Reconstruction

Plastic surgeon Andrea Pusic discussed some women’s initial aversion to breast reconstruction at the beginning of treatment. Only about a third of women undergo immediate breast reconstruction after mastectomy, according to a 2011 analysis in the Annals of Surgical Oncology, with 11.5 percent delaying reconstructive surgery for months or years, and more than half of patients foregoing it altogether.

May 24, 2012
Smoking Gene May Reveal Why Some People Smoke More

A study led by molecular epidemiologist Helena Furberg reported the discovery of a gene that predicts smoking behavior. Dr. Furberg noted that the next research step would be to see if currently available smoking cessation medications would work differently in people who carry these genes.

May 22, 2012
Moderate Weight Loss Can Decrease Breast Cancer Risk

Breast Cancer Medicine Chief Clifford Hudis commented on the connection between obesity and breast cancer risk in postmenopausal women. Cancer researchers believe fat tissue becomes a major source of estrogen, which causes certain types of tumors in the breast to grow.

May 22, 2012
Lung Cancer Tests Advised for Some Heavy Smokers

In collaboration with the American College of Chest Physicians and the American Society of Clinical Oncology, epidemiologist and physician Peter Bach led an effort to develop clinical guidelines for lung cancer screening in smokers. Published in the Journal of the American Medical Association, the guidelines were widely covered by mainstream media, including the Associated Press, Bloomberg, and HealthDay News.

May 20, 2012
Cancer Survivors Face a New Challenge in Care

Survivorship Initiative Director Mary McCabe commented on the importance of cancer survivorship programs. She said these programs ensure that cancer survivors receive proper follow-up care and teach survivors how to communicate their needs to their healthcare team.

May 17, 2012
Aveo Kidney Cancer Drug More Tolerated Than Nexavar

Medical oncologist Robert Motzer discussed encouraging findings from a phase III study he led comparing the safety and efficacy of two kidney cancer drugs. Dr. Motzer’s team found that patients taking the investigational drug tivozanib were half as likely to need a break from the medication due to side effects as patients taking sorafenib (Nexavar®).

May 16, 2012
Complex Immune-Based Cancer Treatment Shows Signs of Progress

Michel Sadelain, Center for Cell Engineering Director, discussed the burgeoning field of adoptive cell transfer (ACT) as a treatment for cancer. Dr. Sadelain, who is involved in several ACT trials at Memorial Sloan Kettering, notes that interest in these types of cell-based therapies is growing, but serious hurdles must be overcome if any form of ACT is to become widely available.

May 15, 2012
With Biotechs Back in Limelight, OPKO's Alzheimer's Diagnostic and Other Products Catch Investors' Eye

Surgery Department Chair Peter Scardino spoke about biomarkers developed at Memorial Sloan Kettering that, when used together with PSA tests, can reduce the need for prostate biopsies by more than 50 percent.

May 13, 2012
Finding a Match, and a Mission: Helping Blacks Survive Cancer

Memorial Sloan Kettering patient Seun Adebiyi launched Nigeria’s national bone marrow registry after experiencing firsthand the difficulty of finding donors for patients of African descent.

May 12, 2012
Sunscreen Fears

Dermatologist Kishwer Nehal was interviewed about research from Missouri University of Science and Technology that looked at what happens to cells containing zinc oxide when exposed to sunlight.

May 11, 2012
Risky Surgical Business

Gynecologic oncologist Douglas Levine spoke about risk-reducing surgery for carriers of BRCA gene mutations. BRCA gene mutations, which are much more prevalent in Jewish people of Ashkenazi descent than in the general population, increase the likelihood of developing ovarian or breast cancer.

May 8, 2012